Abstract
This work has explored the possibility that alterations of NK activity induced by the opioid pentapeptide leu-enkephalin (LENK) may reflect the alterations in secretion of IFN, an important regulator of NK activity. The NK activity in the spleen of mice was determined in parallel with the plasma IFN level 24 and 48h after an i. p. injection of LENK (10 mg/kg). A known inducer of IFN secretion, polyinosinic-polycytidylic acid (poly-IC), was also used. LENK injection significantly increased basal IFN secretion 24 and 48h later. The level was comparable to that induced by poly-IC. However, LENK was not able to augment the poly-IC-increased IFN level. The increase of IFN at 48 h coincided with a mild enhancement of NK activity in the spleens, but 24 h after LENK injection, the increased IFN level in plasma was associated with a significant drop of splenic NK activity. LENK did not affect the NK activity stimulated with poly-IC. Naloxone (20 mg/kg), an opioid receptor-blocking agent, only partly diminished the LENK-induced IFN secretion. However, naloxone itself increased the plasma IFN level. These data indicate that the immunomodulatory effects of the opioid peptide LENK in vivo are associated with alterations of IFN secretion.
Similar content being viewed by others
References
Apte RN, Durum SK, Oppenheim JJ (1990) Opioids modulate interleukin-1 production and secretion by bone-marrow macrophages. Immunol Lett 24:141–148
Carr DJJ, Kim CH, DeCosta B, Jacobson AE, Rice KC, Blalock JE (1988) Evidence for a δ-class opioid receptor on cells of the immun system. Cell Immunol 116:44–51
Brown SL, Epps DE van (1985) Suppression of T lymphocyte chemotactic factor production by the opioid peptide β-endorphin and met-enkephalin. J Immunol 134:3384–3390
Brown SL, Epps DE van (1986) Opioid peptides modulate production of interferon ψ by human mononuclear cells. Cell Immunol 103:19–26
Brummit CF, Sharp BM, Gekker G, Keane WF, Peterson PF (1988) Modulatory effects of β-endorphin on interferon-ψ production by cultured peripheral blood mononuclear cells: heterogeneity among donors and the influence of cultured medium. Brain Behav Immun 2:187–198
Faith RE, Murgo AJ (1988) Inhibition of pulmonary metastases and enhancement of natural killer cell activity by methionine-enkephalin. Brain Behav Immun 2:114–122
Foris G, Medgyesi GA, Hack M (1986) Bidirectional effect of met-enkephalin on macrophage effector functions. Mol Cell Biochem 69:127–137
Forti RL, Moldovan RA, Mitchell WM, Callicoat P, Schuffman SS, Davies HA, Smith DM (1985) Application of an objective biological assay of human interferons to clinical specimens and a survey of a normal population. J Clin Microbiol 21:689–693
Gabrilovac J, Martin-Kleiner I, Osmak M (1990) Modulation of NK and ADCC activities by leu-enkephalin in vivo and in vitro. Period Biol 92:79–81
Gabrilovac J, Antica M, Osmak M (1992) In vivo bidirectional regulation of mouse natural killer (NK) cell cytotoxic activities by leu-enkephalin: reversibility by naloxone. Life Sci 50:29–37
Gabrilovac J, Martin-Kleiner I, Ikic-Sutlic M, Osmak M (1992) Interaction of leu-enkephalin and α-interferon in modulation of NK-activity of human peripheral blood lymphocytes. Ann N Y Acad Sci 650:140–145
Gabrilovac J, Martin-Kleiner I, Kummer U, Thierfelder S (1994) Leu-enkephalin modulates proliferative ability and IL-2 secretion of mouse spleen cells. Period Biol 96:273–274 (Abstract)
Hagi K, Uno K, Inaba K, Muramatsu S (1994) Augmenting effects of opioid peptides on murine macrophage activation. J Neuroimmunol 50:71–76
Hucklebridge FH, Hudspith BN, Muhamed J, Lydyard PM, Brostoff J (1989) Methionineenkephalin stimulates in vitro proliferation of human peripheral lymphocytes via δ-opioid receptors. Brain Behav Immun 3:183–189
Jankovic BD, Maric D (1987) Enkephalins and immunity. I. In vivo suppression and potentiation of humoral immune response. Ann N Y Acad Sci 496:115–125
Johnson HM, Smith EM, Torres BA, Blalock (1982) Regulation of the in vitro antibody response by neuroendocrine hormones. Proc. Natl Acad Sci USA 79:4171–4174
Kastin AJ, Seligson J, Strimas JH, Chi DS (1991) Failure of met-enkephalin to enhance natur killer cells. Immunobiology 183:55–68
Kusnecov AW, Husband AJ, King MG, Pang G, Smith R (1987) In vivo effects of β-endorphin on lymphocyte proliferation and interleukin 2 production. Brain Behav Immun 1:88–97
Mandler RN, Biddison WE, Mandler R, Serrate SA (1986) β-endorphin augments the cytolytic activity and interferon production of natural killer cells. J Immunol 136:934–939
Marotti T, Sverko V, Hrsak I (1990) Modulation of superoxide anion release from human polymorphonuclear cells by met- and leu-enkephalin. Brain Behav Immun 4:13–22
Marotti T, Burek B, Rabatic S, Balog T, Hrsak I (1994) Modulation of lipopolysaccharideinduced production of cytokines by methionine-enkephalin. Immunol Lett 40:43–47
Oleson DR, Johnson DR (1988) Regulation of human natural cytotoxicity by enkephalins and selective opiate agonists. Brain Behav Immun 2:171–186
Prete P, Levin ER, Padram A (1986) The in vitro effects of endogenous opiates on natural killer cells, antigen-specific cytolytic T-cells, and T-cell subsets. Exp Neurol 92:349–359
Shavit Y, DePaulis A, Martin FC, Terman GW, Pechnick RN, Zane CJ, Gaele RP, Liebeskind JC (1986) Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc Natl Acad Sci USA 83:7114–7117
Bergh P van den, Rozing J, Nagelkerken J (1991) Two opposing modes of action of β-endorphin on lymphocyte function. Immunology 72:537–543
Bergh P van den, Dobber R, Ramlal S, Rozing J, Nagelkerken L (1984) Role of opioid peptides in the regulation of cytokine production by murine CD4+ T cells. Cell Immunol 154:109–122
Weigent DA, Blalock JE (1987) Interaction between the neuroendocrine and immune systems: common hormones and receptors. Immunol Rev 100:79–108
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gabrilovac, J., Ikic-Sutlic, M., Knezevic, N. et al. Leu-enkephalin enhances interferon secretion in mice. Res. Exp. Med. 196, 137–144 (1996). https://doi.org/10.1007/BF02576835
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02576835